Table 5.

Comparison of statistical significance of BMI, RBS, and FHA at various treatment levels.

Levels	Levels	BMI Female	BMI Male	RBS Female	RBS Male	FHA Female	FHA Male
T0	T1	P∗	P∗∗	NS	NS	P∗∗∗	P∗∗∗
	T2	P∗∗∗	P∗∗∗	NS	NS	NS	P∗
	T3	P∗∗∗	P∗∗∗	NS	NS	NS	NS
	T4	P∗	NS	P∗∗∗	P∗∗∗	NS	NS
	T5	NS	NS	P∗∗∗	P∗∗∗	NS	NS
T1
	T2	P∗	NS	NS	NS	NS	NS
	T3	NS	NS	NS	NS	NS	NS
	T4	NS	NS	P∗∗∗	P∗	NS	P∗∗
	T5	NS	NS	P∗∗∗	P∗∗	P∗∗∗	P∗∗∗
T2
	T3	NS	NS	NS	NS	NS	NS
	T4	NS	NS	P∗∗∗	P∗	NS	P∗∗∗
	T5	NS	NS	P∗∗∗	P∗∗	P∗∗∗	P∗∗∗
T3
	T4	NS	NS	P∗∗	NS	NS	P∗∗∗
	T5	NS	NS	P∗∗∗	NS	P∗∗∗	P∗∗∗
T4
	T5	NS	NS	NS	NS	NS	P∗

P∗: significant; P∗∗: highly significant; P∗∗∗: extremely significant; NS: not significant. BMI scores showed no significant changes between T0 and T5 in both genders. The Rosenberg scale showed significant changes between T0 and T5 in females and males. FHA scores showed significant changes from T0 to T1, and T1 to T5 in males and females. BMI and FHA scores showed no significant changes between T0 (at the beginning of the treatment) and T5 (at the end of 12 months).